Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ACTU

Actuate Therapeutics, Inc. Common stock

XNAS

$1.23+8.85%+$0.1000Prev $1.13LIVE Full chart Live alerts
No recent price bars, the chart lights up when ACTU starts printing.

Why is ACTU up today? It is at $1.23 (+8.85%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACTU spikes, and full due diligence on ACTU — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $ACTU alerts the moment volume spikes

Our scanner flagged $ACTU 2 times in the last 30 days. Create a free account to track $ACTU, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$1.23
Change today
+8.85%
Previous close
$1.13
52-week range
$1.02 – $9.22
Valuation & dividend
Market cap
$27M
Ownership & volume
Shares outstanding
23.9M
SEC · as of 2026-05-13 · 85d
Institutional own.
60.09%
Total held
60.1%
Tradeable float
9.5M
40% of shares · after 60% institutions
Short interest
755K
▲ +10% vs prior · as of 2026-07-15
Short % of float
7.9%
Days to cover
1.0d
Avg daily volume
131K
Next earnings
Aug 13 · in 7d
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
0.7x
15m
2.5x
1h
2.2x
1D
0.8x

Get free ACTU + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $ACTU up today?

Here is the latest on ACTU from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →
Why is $ACTU moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 7dLow float · 9.5M shShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy4 analysts
Avg target $9.50(+672% upside)
Range $5 – $15
4 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

5 open-market buys0 buys, 0 sells last 3 months (0/2 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Schmitt Daniel M
Officer
Sold (automatic/other)-122K
0.5% of company
sold 45%150K$528K
at $4.33
Feb 13, 26
Schmitt Daniel M
Officer
Other272K
1.1% of company
n/a272Kn/aFeb 13, 26
Thomson Todd S
Director
Sold (automatic/other)-280K
1.2% of company
sold 11%2.35M$1.6M
at $5.80
Jan 5, 26
Fletcher Aaron G.L.
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25
Kreis Leslie W.
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25
Bios Equity Cof, Lp
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25
Kreis Leslie W.
Beneficial Owner (10%)
Bought (open market)+500K
2.1% of company
added 66%1.26M$4.0M
at $8.00
Aug 14, 24
Kreis Leslie W.
Beneficial Owner (10%)
Acquired (grant/award)+9.38M
39.2% of company
n/a2.51Mn/aAug 14, 24
Kreis Leslie W.
Beneficial Owner (10%)
Sold (automatic/other)-25K
0.1% of company
sold 0.3%9.89M$225K
at $9.00
Aug 14, 24
Kreis Leslie W.
Beneficial Owner (10%)
Other38K
0.2% of company
added 4.0%998K$200K
at $5.27
Aug 14, 24
Fletcher Aaron G.L.
Director
Bought (open market)+500K
2.1% of company
added 66%1.26M$4.0M
at $8.00
Aug 14, 24
Fletcher Aaron G.L.
Director
Acquired (grant/award)+9.38M
39.2% of company
n/a2.51Mn/aAug 14, 24

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $ACTU runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$ACTU Sentiment

Bullish
Bearish100Bullish
📰 News: 3 bull · 0 bearToday: +8.8%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ACTU Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 15d ago -4.76%
$ACTU moved -4.76% in 1 min (Level 1) at 1:07 PM ET
at $1.27
Alert· 15d ago 24.6× RVOL
ACTU hit 24.603x RVOL at 1:07 PM ET
at $1.28
News· SEC EDGAR· 19d ago
ACTUATE THERAPEUTICS, INC. filed an 8-K: Delisting / Listing Deficiency
News· GlobeNewswire Inc.· 66d ago Bullish
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
News· SEC EDGAR· 75d ago
ACTUATE THERAPEUTICS, INC. filed an 8-K: Shareholder Vote
News· SEC EDGAR· 83d ago
ACTUATE THERAPEUTICS, INC. filed a Quarterly report (10-Q)
News· SEC EDGAR· 86d ago
ACTUATE THERAPEUTICS, INC.: Announces FDA Clearance of IND for Oral Elraglusib
News· GlobeNewswire Inc.· 154d ago Bullish
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
News· Benzinga· 328d ago Neutral
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
News· GlobeNewswire Inc.· 431d ago Bullish
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

ACTU stock FAQ

Why is $ACTU up today?

Here is the latest on ACTU from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the ACTU stock price today?

ACTU last traded at $1.23, up 8.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does ACTU report earnings?

Actuate Therapeutics, Inc. Common stock (ACTU) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live ACTU alerts?

The ACTU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACTU 2 times in the last 30 days.

What exchange is ACTU on?

ACTU (Actuate Therapeutics, Inc. Common stock) trades on XNAS, with a market cap of about $27M.

Is ACTU good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACTU for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.